Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: A 10-year systematic literature review (SLR)
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: A 10-year systematic literature review (SLR) |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Anota A., Pozet A., Lefevre C., Lemasson H., Cotte F-E., Guerzider S., Mouillet G., Eberst G., Charton E., Westeel V. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 30 |
| Date Published | DEC |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |